Began in Feb, 2018, Aisono defines itself as a social enterprise which aims to solve the critical social issues in breast health industry.
Solution: Based on the main four technologies- Ultrasound Tech, Robotics, Artificial Intelligence and Machine Vision, AIBUS can progress the breast scanning automatically. The device has high cost-efficiency. Meanwhile, it may solve the issue that lack of sonographers in rural areas. Therefore, the efficient population-based breast screening will be achieved. Increasingly more breast cancer patients may be diagnosed and treated at the early stage, and it will decrease the breast cancer mortality rate nationwide.
Progress: Since 2018, Aisono has served as the first AI breast cancer screening solution provider for National Program in China. The 1st station started at Changting country, Fujian where 700K people stay. (Rural Mode)
In second half year of 2019, we are launching the AI solution for Nanshan district, Shenzhen. About half million urban females will be ranged.(Urban Mode)
In financial term, Aisono just completed the pre-A turn funding, valued at 500M RMB.
Company’s Keywords:
ultrasonics, artificial intelligence, robotics, breast health management, populationbased screening, breast cancer
<4
<
<2018